Maternal-Fetal Aspects of Autoimmune Disease

Handbook of Systemic Autoimmune Diseases

Volumn 4, Issue , 2005, Pages 11-28

  Lambert, Nathalie C ^a   Reed, Ann M ^b  

^a INSERM   (France)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649641311     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(05)04003-1     Document Type: Review

References (106)

1. Ando T., Imaizumi M., Graves P.N., Unger P., and Davies T.F. Intrathyroidal fetal microchimerism in Graves' disease. J. Clin. Endocrinol. Metab. 87 (2002) 3315-3320
2. Ansari A.A., Fett J.D., Carraway R.E., Mayne A.E., Onlamoon N., and Sundstrom J.B. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin. Rev. Allergy Immunol. 23 (2002) 301-324
3. Aractingi S., Sibilia J., Meignin V., Launay D., Hachulla E., Le Danff C., Janin A., and Mariette X. Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjögren's syndrome. Arthritis Rheum. 46 (2002) 1039-1043
4. Artlett C.M., Cox L.A., and Jimenez S.A. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens. Arthritis Rheum. 43 (2000) 1062-1067
5. Artlett C.M., Cox L.A., Ramos R.C., Dennis T.N., Fortunato R.A., Hummers L.K., Jimenez S.A., and Smith J.B. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Clin. Immunol. 103 (2002) 303-308
6. Artlett C.M., O'Hanlon T.P., Lopez A.M., Song Y.W., Miller F.W., and Rider L.G. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals. Arthritis Rheum. 48 (2003) 2567-2572
7. Artlett C.M., Ramos R., Jiminez S.A., Patterson K., Miller F.W., and Rider L.G. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 356 (2000) 2155-2156
8. Artlett C.M., Smith J.B., and Jimenez S.A. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N. Engl. J. Med. 338 (1998) 1186-1191
9. Ashkar A.A., Di Santo J.P., and Croy B.A. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192 (2000) 259-270
10. Barakonyi A., Polgar B., and Szekeres-Bartho J. The role of gamma/delta T-cell receptor-positive cells in pregnancy: part II. Am. J. Reprod. Immunol. 42 (1999) 83-87
11. Berry S.M., Hassan S.S., Russell E., Kukuruga D., Land S., and Kaplan J. Association of maternal histocompatibility at class II HLA loci with maternal microchimerism in the fetus. Pediatr. Res. 56 (2004) 73-78
12. Bianchi D.W., Zickwolf G.K., Weil G.J., Sylvester S., and DeMaria M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl. Acad. Sci. USA 93 (1996) 705-708
13. Billington W.D. Influence of immunological dissimilarity of mother and foetus on size of placenta in mice. Nature 202 (1964) 317-318
14. Boehm B.O., Kuhnl P., Loliger C., Ketzler-Sasse U., Holzberger G., Seidl S., Bauerle R., Schifferdecker E., and Usadel K.H. HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors. Clin. Investig. 71 (1993) 221-225
15. Borish L.C., and Steinke J.W. 2. Cytokines and chemokines. J. Allergy Clin. Immunol. 111 (2003) S460-S475
16. Boutjdir M., Chen L., Zhang Z.H., Tseng C.E., DiDonato F., Rashbaum W., Morris A., el-Sherif N., and Buyon J.P. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ. Res. 80 (1997) 354-362
17. Burastero S.E., Galbiati S., Vassallo A., Sabbadini M.G., Bellone M., Marchionni L., Smid M., Ferrero E., Ferrari A., Ferrari M., and Cremonesi L. Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosis. Arthritis Rheum. 48 (2003) 1109-1116
18. Check J.H., Ostrzenski A., and Klimek R. Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women. Am. J. Reprod. Immunol. 37 (1997) 330-334
19. Clancy R.M., and Buyon J.P. Clearance of apoptotic cells: TGF-beta in the balance between inflammation and fibrosis. J. Leukoc. Biol. 74 (2003) 959-960
20. Clancy R.M., and Buyon J.P. Autoimmune-associated congenital heart block: dissecting the cascade from immunologic insult to relentless fibrosis. Anat. Rec. 280A (2004) 1027-1035
21. Corpechot C., Barbu V., Chazouilleres O., and Poupon R. Fetal microchimerism in primary biliary cirrhosis. J. Hepatol. 33 (2000) 696-700
22. Endo Y., Negishi I., and Ishikawa O. Possible contribution of microchimerism to the pathogenesis of Sjögren's syndrome. Rheumatology (Oxford) 41 (2002) 490-495
23. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., and Nelson J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 93 (1999) 2033-2037
24. Fanning P.A., Jonsson J.R., Clouston A.D., Edwards-Smith C., Balderson G.A., Macdonald G.A., Crawford D.H., Kerlin P., Powell L.W., and Powell E.E. Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J. Hepatol. 33 (2000) 690-695
25. Finkel S.I., and Lilly F. Influence of histoincompatibility between mother and foetus on placental size in mice. Nature 234 (1971) 102-103
26. Greeley S.A., Katsumata M., Yu L., Eisenbarth G.S., Moore D.J., Goodarzi H., Barker C.F., Naji A., and Noorchashm H. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat. Med. 8 (2002) 399-402
27. Imaizumi M., Pritsker A., Unger P., and Davies T.F. Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 143 (2002) 247-253
28. Johnson K.L., McAlindon T.E., Mulcahy E., and Bianchi D.W. Microchimerism in a female patient with systemic lupus erythematosus. Arthritis Rheum. 44 (2001) 2107-2111
29. Johnson K.L., Nelson J.L., Furst D.E., McSweeney P.A., Roberts D.J., Zhen D.K., and Bianchi D.W. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum. 44 (2001) 1848-1854
30. Jonsson Y., Ekerfelt C., Berg G., Nieminen K., Sharma S., Ernerudh J., and Matthiesen L. Systemic Th1/Th2 cytokine responses to paternal and vaccination antigens in preeclampsia: no differences compared with normal pregnancy. Am. J. Reprod. Immunol. 51 (2004) 302-310
31. Kane S., Kisiel J., Shih L., and Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am. J. Gastroenterol. 99 (2004) 1523-1526
32. Khosrotehrani K., Mery L., Aractingi S., Bianchi D.W., and Johnson K.L. Absence of fetal cell microchimerism in cutaneous lesions of lupus erythematosus. Ann. Rheum. Dis. 64 (2005) 159-160
33. Klintschar M., Schwaiger P., Mannweiler S., Regauer S., and Kleiber M. Evidence of fetal microchimerism in Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 86 (2001) 2494-2498
34. Koczwara K., Bonifacio E., and Ziegler A.G. Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53 (2004) 1-4
35. Kuroki M., Okayama A., Nakamura S., Sasaki T., Murai K., Shiba R., Shinohara M., and Tsubouchi H. Detection of maternal-fetal microchimerism in the inflammatory lesions of patients with Sjögren's syndrome. Ann. Rheum. Dis. 61 (2002) 1041-1046
36. Lambert N.C. HLA-DQA1 as a risk factor for microchimerism: comment on the article by Artlett et al. Arthritis Rheum. 50 (2004) 2713
37. Lambert N.C., Erickson T.D., Yan Z., Pang J.M., Guthrie K.A., Furst D.E., and Nelson J.L. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum. 50 (2004) 906-914
38. Lambert N.C., Evans P.C., Hashizumi T.L., Maloney S., Gooley T., Furst D.E., and Nelson J.L. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J. Immunol. 164 (2000) 5545-5548
39. Lambert N.C., Lo Y.M., Erickson T.D., Tylee T.S., Guthrie K.A., Furst D.E., and Nelson J.L. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 100 (2002) 2845-2851
40. Lambert N.C., Stevens A.M., Tylee T.S., Erickson T.D., Furst D.E., and Nelson J.L. From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann. NY Acad. Sci. 945 (2001) 164-171
41. Le Bouteiller P. HLA class I chromosomal region, genes, and products: facts and questions. Crit. Rev. Immunol. 14 (1994) 89-129
42. Lee LA R.B., and Harnon C. Autoantibodies to SS-A/Ro in congenital heart block. Arthritis Rheum. 20 (1982) S24
43. Lio D., Candore G., Romano G.C., D'Anna C., Gervasi F., Di Lorenzo G., Modica M.A., Potestio M., and Caruso C. Modification of cytokine patterns in subjects bearing the HLA-B8,DR3 phenotype: implications for autoimmunity. Cytokines Cell Mol. Ther. 3 (1997) 217-224
44. Lo E.S., Lo Y.M., Hjelm N.M., and Thilaganathan B. Transfer of nucleated maternal cells into fetal circulation during the second trimester of pregnancy. Br. J. Haematol. 100 (1998) 605-606
45. Lo Y.M., Lau T.K., Chan L.Y., Leung T.N., and Chang A.M. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin. Chem. 46 (2000) 1301-1309
46. Lombardi T., Philippeaux M.M., Hadengue A., Samson J., Borisch B., and Rubbia-Brandt L. Absence of leukocyte microchimerism in oral lichen planus (OLP): an in situ hybridisation study. J. Oral Pathol. Med. 30 (2001) 398-401
47. Maloney S., Smith A., Furst D.E., Myerson D., Rupert K., Evans P.C., and Nelson J.L. Microchimerism of maternal origin persists into adult life. J. Clin. Invest. 104 (1999) 41-47
48. Matthiesen L., Ekerfelt C., Berg G., and Ernerudh J. Increased numbers of circulating interferon-gamma- and interleukin-4-secreting cells during normal pregnancy. Am. J. Reprod. Immunol. 39 (1998) 362-367
49. Mellor A.L., and Munn D.H. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?. Immunol. Today 20 (1999) 469-473
50. Miranda-Carus M.E., Boutjdir M., Tseng C.E., DiDonato F., Chan E.K., and Buyon J.P. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J. Immunol. 161 (1998) 5886-5892
51. Miyashita Y., Ono M., Ueki H., and Kurasawa K. Y chromosome microchimerism in rheumatic autoimmune disease. Ann. Rheum. Dis. 59 (2000) 655-656
52. Morales P.J., Pace J.L., Platt J.S., Phillips T.A., Morgan K., Fazleabas A.T., and Hunt J.S. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J. Immunol. 171 (2003) 6215-6224
53. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., and Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
54. Murata H., Nakauchi H., and Sumida T. Microchimerism in Japanese women patients with systemic sclerosis. Lancet 354 (1999) 220
55. Nagaeva O., Jonsson L., and Mincheva-Nilsson L. Dominant IL-10 and TGF-beta mRNA expression in gamma deltaT cells of human early pregnancy decidua suggests immunoregulatory potential. Am. J. Reprod. Immunol. 48 (2002) 9-17
56. Nakagome Y., Nagafuchi S., and Nakahori Y. Prenatal sex determination. Lancet 335 (1990) 291
57. Nakagome Y., Nagafuchi S., Seki S., Nakahori Y., Tamura T., Yamada M., and Iwaya M. A repeating unit of the DYZ1 family on the human Y chromosome consists of segments with partial male-specificity. Cytogenet. Cell Genet. 56 (1991) 74-77
58. Nelson J.L. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune?. Arthritis Rheum. 39 (1996) 191-194
59. Nelson J.L., Furst D.E., Maloney S., Gooley T., Evans P.C., Smith A., Bean M.A., Ober C., and Bianchi D.W. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351 (1998) 559-562
60. Nelson J.L., Hughes K.A., Smith A.G., Nisperos B.B., Branchaud A.M., and Hansen J.A. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N. Engl. J. Med. 329 (1993) 466-471
61. Nield L.E., Silverman E.D., Taylor G.P., Smallhorn J.F., Mullen J.B., Silverman N.H., Finley J.P., Law Y.M., Human D.G., Seaward P.G., Hamilton R.M., and Hornberger L.K. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 105 (2002) 843-848
62. Ober C. HLA and pregnancy: the paradox of the fetal allograft. Am. J. Hum. Genet. 62 (1998) 1-5
63. Ohtsuka T., Miyamoto Y., Yamakage A., and Yamazaki S. Quantitative analysis of microchimerism in systemic sclerosis skin tissue. Arch. Dermatol. Res. 293 (2001) 387-391
64. Østensen M., Forger F., Nelson J.L., Schuhmacher A., Hebisch G., and Villiger P.M. Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann. Rheum. Dis. 64 (2005) 839-844
65. Pazmany L., Mandelboim O., Vales-Gomez M., Davis D.M., Reyburn H.T., and Strominger J.L. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274 (1996) 792-795
66. Piccinni M.P., Giudizi M.G., Biagiotti R., Beloni L., Giannarini L., Sampognaro S., Parronchi P., Manetti R., Annunziato F., Livi C., et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 155 (1995) 128-133
67. Pollack M.S., Kirkpatrick D., Kapoor N., Dupont B., and O'Reilly R.J. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N. Engl. J. Med. 307 (1982) 662-666
68. Poole J.A., and Claman H.N. Immunology of pregnancy. Implications for the mother. Clin. Rev. Allergy Immunol. 26 (2004) 161-170
69. Portanova J.P., and Kotzin B.L. Lupus-like autoimmunity in murine graft-versus-host disease. Concepts Immunopathol 6 (1988) 119-140
70. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189 (1999) 1093-1100
71. *0301 molecule. J. Immunol. 159 (1997) 6260-6265
72. Reed A.M., McNallan K., Wettstein P., Vehe R., and Ober C. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis?. J. Immunol. 172 (2004) 5041-5046
73. Reed A.M., Picornell Y.J., Harwood A., and Kredich D.W. Chimerism in children with juvenile dermatomyositis. Lancet 356 (2000) 2156-2157
74. Reed A.M., Shock L.P., and Picornell J. Microchimerism in children with juvenile dermatomyositis. Arthritis Rheum. 41 (1998) S264
75. Reichlin M., Brucato A., Frank M.B., Maddison P.J., McCubbin V.R., Wolfson-Reichlin M., and Lee L.A. Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum. 37 (1994) 1698-1703
76. Roberts C.W., Walker W., and Alexander J. Sex-associated hormones and immunity to protozoan parasites. Clin. Microbiol. Rev. 14 (2001) 476-488
77. Rubbia-Brandt L., Philippeaux M.M., Chavez S., Mentha G., Borisch B., and Hadengue A. FISH for Y chromosome in women with primary biliary cirrhosis: lack of evidence for leukocyte microchimerism. Hepatology 30 (1999) 821-822
78. Rukavina D., and Gill III T.J. Immunobiology and immunopathology of early pregnancy. Early Pregnancy 3 (1997) 141-145
79. Sanchez-Ramon S., Navarro A.J., Aristimuno C., Rodriguez-Mahou M., Bellon J.M., Fernandez-Cruz E., and Andres C. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol. Lett. 96 (2005) 195-201
80. Scaletti C., Vultaggio A., Bonifacio S., Emmi L., Torricelli F., Maggi E., Romagnani S., and Piccinni M.P. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum. 46 (2002) 445-450
81. Schoniger-Hekele M., Muller C., Ackermann J., Drach J., Wrba F., Penner E., and Ferenci P. Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis. Dig. Dis. Sci. 47 (2002) 1909-1914
82. Schrocksnadel H., Baier-Bitterlich G., Dapunt O., Wachter H., and Fuchs D. Decreased plasma tryptophan in pregnancy. Obstet. Gynecol. 88 (1996) 47-50
83. Scott J.S., Maddison P.J., Taylor P.V., Esscher E., Scott O., and Skinner R.P. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N. Engl. J. Med. 309 (1983) 209-212
84. Selva-O'Callaghan A., Boeckh-Behrens T.M., Balada-Prades E., Solans-Laque R., and Vilardell-Tarres M. Fetal microchimerism and inflammatory myopathies. Lancet 357 (2001) 887
85. Selva-O'Callaghan A., Mijares-Boeckh-Behrens T., Prades E.B., Solans-Laque R., Simeon-Aznar C.P., Fonollosa-Pla V., and Vilardell-Tarres M. Lack of evidence of foetal microchimerism in female Spanish patients with systemic sclerosis. Lupus 12 (2003) 15-20
86. Setiady Y.Y., Samy E.T., and Tung K.S. Maternal autoantibody triggers de novo T cell-mediated neonatal autoimmune disease. J. Immunol. 170 (2003) 4656-4664
87. Shevach E.M. Regulatory T cells in autoimmmunity*. Annu. Rev. Immunol. 18 (2000) 423-449
88. Shevach E.M., McHugh R.S., Thornton A.M., Piccirillo C., Natarajan K., and Margulies D.H. Control of autoimmunity by regulatory T cells. Adv. Exp. Med. Biol. 490 (2001) 21-32
89. Srivatsa B., Srivatsa S., Johnson K.L., and Bianchi D.W. Maternal cell microchimerism in newborn tissues. J. Pediatr. 142 (2003) 31-35
90. Srivatsa B., Srivatsa S., Johnson K.L., Samura O., Lee S.L., and Bianchi D.W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 358 (2001) 2034-2038
91. Stassi G., Todaro M., De Maria R., Candore G., Cigna D., Caruso C., Galluzzo A., and Giordano C. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals. Hum. Immunol. 55 (1997) 39-45
92. Stevens A.M., Hermes H.M., Lambert N.C., Nelson J.L., Meroni P.L., and Cimaz R. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block. Rheumatology (Oxford) 44 (2005) 187-191
93. Stevens A.M., Hermes H.M., Rutledge J.C., Buyon J.P., and Nelson J.L. Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 362 (2003) 1617-1623
94. Stevens A.M., Tsao B.P., Hahn B.H., Guthrie K., Lambert N.C., Porter A.J., Tylee T.S., and Nelson J.L. Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 2768-2773
95. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int. Rev. Immunol. 21 (2002) 471-495
96. Takahashi K., Juji T., Miyamoto M., Uchida S., Akaza T., Tadokoro K., Shibata Y., Ino T., and Hidano A. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group. Lancet 343 (1994) 700-702
97. Tanaka A., Lindor K., Gish R., Batts K., Shiratori Y., Omata M., Nelson J.L., Ansari A., Coppel R., Newsome M., and Gershwin M.E. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis. Hepatology 30 (1999) 833-838
98. Tanei R., Yokono H., Motoori T., and Katsuoka K. Microchimerism seems uninvolved in the pathogenesis of idiopathic lichen planus. Dermatology 201 (2000) 373-374
99. Thorsby E. Invited anniversary review: HLA associated diseases. Hum. Immunol. 53 (1997) 1-11
100. Toda I., Kuwana M., Tsubota K., and Kawakami Y. Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome. Ann. Rheum. Dis. 60 (2001) 248-253
101. Vabres P., Malinge M.C., Larregue M., and Bonneau D. Microchimerism from a dizygotic twin in juvenile ulcerative lichen planus. Lancet 359 (2002) 1861-1862
102. van der Meer A., Lukassen H.G., van Lierop M.J., Wijnands F., Mosselman S., Braat D.D., and Joosten I. Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. Mol. Hum. Reprod. 10 (2004) 189-195
103. Vassiliadis S., Ranella A., Papadimitriou L., Makrygiannakis A., and Athanassakis I. Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediators Inflamm 7 (1998) 69-72
104. Wagner F.F., and Flegel W.A. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion 35 (1995) 284-291
105. Watson R.M., Lane A.T., Barnett N.K., Bias W.B., Arnett F.C., and Provost T.T. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) 63 (1984) 362-378
106. Wegmann T.G., Lin H., Guilbert L., and Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14 (1993) 353-356